Related Experiment Video
Updated: Jun 4, 2025

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
Published on: April 26, 2017
Alternative polyadenylation in cancer: Molecular mechanisms and clinical application
Ying Zhang1, Zikun Huang2, Weiqing Lu3
1Department of Radiotherapy, Cancer Hospital of Shantou University Medical College, No.7 Raoping Road, Shantou, Guangdong 515041, China; Clinical Research Center, Cancer Hospital of Shantou University Medical College, No.7 Raoping Road, Shantou, Guangdong 515041, China.
Abstract:
Alternative polyadenylation (APA) serves as a crucial mechanism for the posttranscriptional regulation of gene expression and influences gene expression by generating diverse mRNA isoforms. This process is regulated by a diverse array of RNA-binding proteins (RBPs), which selectively bind to specific sequences or structures within the pre-mRNA molecule. Dysregulation of APA and its associated RBPs has been implicated in numerous diseases, including cardiovascular diseases, nervous system disease, and cancer. For instance, aberrant APA events have been observed in several types of tumors, contributing to tumor heterogeneity and affecting key cellular pathways involved in cell proliferation, invasion, metastasis, and response to therapy. This review critically evaluates the current understanding of APA mechanisms and the multifaceted roles of RBPs in orchestrating this intricate process. We highlight recent advancements in high-throughput sequencing and bioinformatics tools that have enhanced our ability to study APA on a genome-wide scale. Moreover, we explored the pathological consequences of APA dysregulation, emphasizing its role in oncogenesis. By elucidating the intricate relationships between APA and RBPs, this review aims to underscore the potential of targeting the APA machinery and RBPs for therapeutic intervention. Understanding these molecular processes holds promise for developing novel diagnostic markers and treatment strategies for a range of human cancers.
Insights
Alternative polyadenylation (APA) regulates gene expression by creating mRNA variants, controlled by RNA-binding proteins (RBPs). Dysregulation of APA and RBPs is linked to cancer, suggesting therapeutic potential.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- Alternative polyadenylation (APA) is a key posttranscriptional regulatory mechanism generating diverse mRNA isoforms.
- RNA-binding proteins (RBPs) control APA by binding to specific pre-mRNA sequences or structures.
- Dysregulation of APA and RBPs is implicated in diseases like cancer, cardiovascular, and nervous system disorders.
Purpose of the Study:
- To review current knowledge on APA mechanisms and the roles of RBPs.
- To highlight advancements in high-throughput sequencing and bioinformatics for studying APA.
- To explore the pathological role of APA dysregulation in oncogenesis and therapeutic potential.
Main Methods:
- Literature review of APA mechanisms and RBP functions.
- Evaluation of high-throughput sequencing and bioinformatics tools for genome-wide APA analysis.
- Analysis of pathological consequences of APA dysregulation in cancer.
Main Results:
- APA generates mRNA diversity, crucial for gene expression regulation.
- RBPs are central regulators of APA, influencing mRNA isoform production.
- Aberrant APA events contribute to tumor heterogeneity and cancer progression.
- APA dysregulation impacts cell proliferation, invasion, metastasis, and therapy response.
Conclusions:
- APA and RBPs play critical roles in normal cellular processes and disease, particularly cancer.
- Targeting APA machinery and RBPs offers potential for novel cancer diagnostics and therapeutics.
- Further research into APA-RBP interactions can lead to innovative treatment strategies for various cancers.
Related Concept Videos
RNA Splicing
Targeted Cancer Therapies
There are several types of targeted therapies against...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
RNA Editing
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Epigenetic Regulation
X-chromosome...

